Literature DB >> 18398269

Comparison of T- and Z-score in identifying risk factors of osteoporosis in inflammatory bowel disease patients.

E Tsironi1, D Hadjidakis, E Mallas, C Tzathas, D G Karamanolis, S D Ladas.   

Abstract

OBJECTIVE: Most studies have shown contradictory results regarding predictive factors of osteoporosis in inflammatory bowel disease (IBD). Since in these studies either T- or Z-scores has been used, our aim was to compare T- and Z-score in identifying risk factors of osteoporosis in IBD patients.
MATERIALS AND METHODS: Bone density was measured by dual X-ray absorptiometry (DXA) at L2-L4 of the spine and femoral neck in 122 patients. Twenty-two clinical parameters were recorded prior to DXA and evaluated by univariate and multivariate analysis.
RESULTS: On multivariate analysis, cumulative steroid dose was a predictive factor of femoral neck T-score (p<0.001) and Z-score (p=0.001). Age was a predictive factor of femoral neck T-score (p<0.001). BMI was a predictive factor of femoral neck Z-score (p=0.03). None of the other 19 variables tested had any predictive value for bone density. Age >or=55 years was a risk factor of low femoral neck T-score (OR 5.08, 95% CI 1.90-13.57, p=0.001), as was cumulative dose of prednisolone >or=5 g (OR 3.41, 95% CI 1.50-7.73, p=0.004).
CONCLUSIONS: There is a discordance of results depending on whether T- or Z-scores are used in analysis. Among 22 parameters, cumulative steroid dose and age proved to be the most important factors.

Entities:  

Mesh:

Year:  2008        PMID: 18398269

Source DB:  PubMed          Journal:  J Musculoskelet Neuronal Interact        ISSN: 1108-7161            Impact factor:   2.041


  8 in total

1.  Osteoporosis in adult Sri Lankan inflammatory bowel disease patients.

Authors:  Arjuna Priyadarsin de Silva; Aranjan Lionel Karunanayake; Thalahitiya Gamaralalage Iruka Dissanayaka; Anuradha Supun Dassanayake; Hewa Kattadi Kankanamgae Tilak Duminda; Arunasalam Pathmeswaran; Ananda Rajitha Wickramasinghe; Hithanadura Janaka de Silva
Journal:  World J Gastroenterol       Date:  2009-07-28       Impact factor: 5.742

2.  The prevalence and risk factors of decreased bone mineral density in firstly diagnosed ulcerative colitis patients in the eastern region of Turkey.

Authors:  Levent Ediz; Ahmet Cumhur Dülger; Murat Toprak; Mehmet Fethi Ceylan; Ozgür Kemik
Journal:  Int J Clin Exp Med       Date:  2011-04-03

Review 3.  Management of Inflammatory Bowel Disease in the Elderly Patient: Challenges and Opportunities.

Authors:  Ashwin N Ananthakrishnan; Tamara Donaldson; Karen Lasch; Vijay Yajnik
Journal:  Inflamm Bowel Dis       Date:  2017-06       Impact factor: 5.325

4.  Prevalence and risk factors for low bone mineral density in ulcerative colitis.

Authors:  Ram Pratap Singh Bundela; Prachis Ashdhir; Kumar Shwetanshu Narayan; Mukesh Jain; Rupesh Kumar Pokharna; Sandeep Nijhawan
Journal:  Indian J Gastroenterol       Date:  2017-06-23

Review 5.  Outcomes and Management of the Ileal Pouch-Anal Anastomosis in the Elderly.

Authors:  James Q Zhou; Sean Michael Duenas; Tarik Kirat; Feza Remzi; Shannon Chang
Journal:  Curr Treat Options Gastroenterol       Date:  2018-09

6.  Dietary ganglioside reduces proinflammatory signaling in the intestine.

Authors:  John Janez Miklavcic; Kareena Leanne Schnabl; Vera Christine Mazurak; Alan Bryan Robert Thomson; Michael Thomas Clandinin
Journal:  J Nutr Metab       Date:  2012-02-12

7.  Low bone mineral density in Greek patients with inflammatory bowel disease: prevalence and risk factors.

Authors:  Ioannis E Koutroubakis; Christos Zavos; John Damilakis; Georgios Z Papadakis; John Neratzoulakis; Nikolaos Karkavitsas; Elias A Kouroumalis
Journal:  Ann Gastroenterol       Date:  2011

8.  Correlation between low bone density and disease activity in patients with ulcerative colitis.

Authors:  Taghi Amiriani; Sima Besharat; Zahra Pourramezan; Honey Sadat Mirkarimi; Mehrdad Aghaei; Hamidreza Joshaghani; Gholamreza Roshandel; Maryam Faghani; Mahsa Besharat
Journal:  Middle East J Dig Dis       Date:  2015-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.